Kamni Vijay is a Life Sciences executive with more than twenty-five years leading global organizations across Genomics, Diagnostics, and healthcare technology. She has served as Chief Executive Officer of an AI-driven drug discovery company, which she guided to a successful exit, and as Vice President and General Manager at Bio-Techne, Becton Dickinson, Agilent Technologies, and Bio-Rad Laboratories, carrying global P&Ls from roughly $100M to more than $2B.
Across those roles she has championed more than half a dozen acquisitions and led the integrations that followed, built and scaled commercial organizations, and shaped policy with members of Congress and the FDA on Diagnostics reimbursement and emergency-use authorization. Today she also serves as an Operating Partner at a San Francisco venture firm and sits on the boards and advisory boards of several companies across Genomics, Spatial Biology, Diagnostics, and AI-driven Discovery.
She holds a PhD in Microbiology from the University of California, Davis, where she was a three-time NIH Research Fellow, and a BA with Honors in Biochemistry and Molecular Biology from Dartmouth College.
She is a member of YPO, Women in Bio, and the Analytical, Life Sciences and Diagnostics Association (ALDA).
